Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115039) titled 'Food Effect Study in Healthy Volunteers of Phase I Flonoltinib Maleate' on Dec. 22, 2025.
Study Type: Interventional study
Study Design:
Cross-over
Primary Sponsor: Chengdu Xinhua Hospital
Condition:
Healthy People
Intervention:
A group:On the morning of the first cycle D1 administration, under fasting conditions, take orally 100mg (2 tablets, specification: 50mg/tablet) of fluorotinib maleate tablets. After a 10 day cleaning period, enter the second cycle of administration, and start eating high-fat, high calorie meals 30 minutes before administration on the morning of D11 in the second cycle
The subjects...